Who makes adrenaline amp 0.5mg?

adrenaline amp 0.5mg is developed by Bozyaka Training and Research Hospital.

What development phase is adrenaline amp 0.5mg in?

adrenaline amp 0.5mg is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

adrenaline amp 0.5mg

Bozyaka Training and Research Hospital · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	adrenaline amp 0.5mg
Also known as	adrenalin codex 0.5mg/1ml injectable solution
Sponsor	Bozyaka Training and Research Hospital
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Comparison of Different Approaches for Supraclavicular Block and Their Effects on Diaphragm Muscle Function (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

adrenaline amp 0.5mg CI brief — competitive landscape report
adrenaline amp 0.5mg updates RSS · CI watch RSS
Bozyaka Training and Research Hospital portfolio CI